(Q45071043)

9 December 2017

Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro (English)

1 reference

9 December 2017

0 references

1 reference

Martin Butzal

1

1 reference

9 December 2017

Sonja Loges

2

1 reference

9 December 2017

Michaela Schweizer

3

1 reference

9 December 2017

Uta Fischer

4

1 reference

9 December 2017

Ursula M Gehling

5

1 reference

9 December 2017

Dieter K Hossfeld

6

1 reference

9 December 2017

Walter Fiedler

7

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Experimental Cell Research

9 December 2017

1 reference

9 December 2017

300

1 reference

9 December 2017

1

1 reference

9 December 2017

65-71

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Mechanisms of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

VEGF and the quest for tumour angiogenesis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Intra-tumoural microvessel density in human solid tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

The predictive value of angiogenesis for adjuvant therapy in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Circulating endothelial cells as a novel marker of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Identification of the hemangioblast in postnatal life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Identification of the adult human hemangioblast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Rapamycin is an effective inhibitor of human renal cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.07.002

10.1016/J.YEXCR.2004.07.002

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference